Skip to content
Devyser
Menu
  • Products
    • Hereditary
      • Thalassemia
        • Devyser Thalassemia NGS
      • Cystic Fibrosis
        • CFTR – Allele Specific
        • Devyser CFTR NGS
      • Familial Hypercholesterolemia
        • Devyser FH NGS
      • Prenatal Aneuploidy
        • Prenatal Aneuploidy
        • Devyser Compact
      • Y Chromosome Microdeletion
        • Devyser AZF
      • Miscarriage Analysis
        • Prenatal Aneuploidy
        • Devyser Thrombophilia
        • Devyser HFE
        • Devyser CVD
      • Reproductive Health
        • Devyser RHD
    • Oncology
      • Breast and Ovarian Cancer
        • Devyser BRCA NGS
        • Devyser HBOC NGS
    • Transplantation
      • Devyser Chimerism NGS
    • Accessories
      • Capillary Electrophoresis
        • Devyser DEV-5 Dye Set
        • 560 Sizer Orange
      • Next Generation Sequencing
        • Devyser Library Clean
        • Devyser Index Plate A
    • Close
  • Order Kits
    • Order Products
    • Distributors
    • Close
  • Resources
    • Updates
      • Events
      • Articles
      • Company News
    • Tools
      • Sequence Coverage Calculator
    • Downloads
      • Whitepapers
      • IFU and Software Settings
      • Batch Release Certificates
    • Close
  • Company
    • About Us
    • Board of Directors
    • Management Team
    • News
    • Career
    • Close
  • Contact
    • Contact Devyser
    • Book a demo
    • Support
    • Distributors
    • Close
Distributor login

Thank you to all visitors

Events / By Emily Carter
Published: November 18, 2019

Last week was a busy week around the globe! Thankyou to everybody who visited us at the conferences in Manila, Rome, Copenhagen and Coimbra! It was lovely to see you and speak to you about improving #genetictesting processes!
#NGS#oncology#Thalassemia#chimerism#aneuploidy

View all events

Post navigation

← Previous Post
Next Post →

Recent Posts

  • Devyser completes private placement of SEK 130 million to Swedbank Robur and AP4
  • Devyser receives Eurostars grant to develop novel DNA test for early detection of transplant rejection
  • Devyser receives MDSAP certification
  • Case Study – A new NGS-based method for chimerism monitoring
  • Major health care providers in Latin America implement Devyser’s solutions to improve post-transplant healthcare management

Archives

  • Products
    • Hereditary
    • Transplantation
    • Reproductive Health
    • Oncology
    • Accessories
  • Order Kits
    • Distributors
  • Resources
    • Articles
    • Calculator
    • Events
  • Downloads
    • Whitepapers
    • IFU and Software settings
    • Certificates
  • Company
    • About Us
    • Board of Directors
    • Management Team
    • Career
    • News
  • Contact
    • Support
Copyright © 2021 Devyser. All rights reserved. Privacy policy | Cookies
  • Home
  • Products
    • Hereditary
      • Devyser Thalassemia NGS
      • CFTR – Allele Specific
      • Devyser CFTR NGS
      • Devyser FH NGS
      • Prenatal Aneuploidy
      • Devyser AZF
      • Devyser Thrombophilia
      • Devyser HFE
      • Devyser CVD
      • Back
    • Oncology
      • Devyser BRCA NGS
      • Devyser HBOC NGS
      • Back
    • Transplantation
      • Devyser Chimerism NGS
      • Back
    • Accessories
      • Devyser DEV-5 Dye Set
      • 560 Sizer Orange
      • Devyser Library Clean
      • Devyser Index Plate A
      • Back
    • Back
  • Order Kits
    • Order products
    • Distributors
    • Back
  • Resources
    • Updates
      • Events
      • Articles
      • Company News
      • Back
    • Calculator
    • Downloads
      • Whitepapers
      • IFU and Software settings
      • Certificates
      • Back
    • Back
  • Company
    • About us
    • Board of Directors
    • Management Team
    • Career
    • News
    • Back
  • Contact